These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22302476)

  • 1. The importance of advanced parental age in the origin of neurofibromatosis type 1.
    Snajderova M; Riccardi VM; Petrak B; Zemkova D; Zapletalova J; Mardesic T; Petrakova A; Lanska V; Marikova T; Bendova S; Havlovicova M; Kaluzova M
    Am J Med Genet A; 2012 Mar; 158A(3):519-23. PubMed ID: 22302476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.
    Dubov T; Toledano-Alhadef H; Bokstein F; Constantini S; Ben-Shachar S
    Mol Genet Genomic Med; 2016 Jul; 4(4):480-6. PubMed ID: 27468422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues.
    Bunin GR; Needle M; Riccardi VM
    Genet Epidemiol; 1997; 14(5):507-16. PubMed ID: 9358268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of parental age on NF1 patients in Turkey.
    Sharafi P; Anlar B; Ersoy-Evans S; Varan A; Yılmaz OF; Turan M; Ayter S
    J Community Genet; 2018 Jul; 9(3):227-232. PubMed ID: 29143198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in von Recklinghausen neurofibromatosis: an hypothesis.
    Zlotogora J
    Am J Med Genet; 1993 Apr; 46(2):182-4. PubMed ID: 8484407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.
    Lázaro C; Ravella A; Gaona A; Volpini V; Estivill X
    N Engl J Med; 1994 Nov; 331(21):1403-7. PubMed ID: 7969279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
    Trevisson E; Forzan M; Salviati L; Clementi M
    Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
    Liu Q; Zoellner N; Gutmann DH; Johnson KJ
    Fam Cancer; 2015 Jun; 14(2):317-24. PubMed ID: 25523354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF1 gene and neurofibromatosis 1.
    Rasmussen SA; Friedman JM
    Am J Epidemiol; 2000 Jan; 151(1):33-40. PubMed ID: 10625171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.
    Riccardi VM; Dobson CE; Chakraborty R; Bontke C
    Am J Med Genet; 1984 May; 18(1):169-76. PubMed ID: 6430086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of neurofibromatosis type 1 (NF1).
    Shen MH; Harper PS; Upadhyaya M
    J Med Genet; 1996 Jan; 33(1):2-17. PubMed ID: 8825042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discounting an adverse maternal effect on severity of neurofibromatosis.
    Riccardi VM; Wald JS
    Pediatrics; 1987 Mar; 79(3):386-93. PubMed ID: 3103092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
    Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
    Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Height assessments in children with neurofibromatosis type 1.
    Soucy EA; van Oppen D; Nejedly NL; Gao F; Gutmann DH; Hollander AS
    J Child Neurol; 2013 Mar; 28(3):303-7. PubMed ID: 22752476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.
    Estivill X; Lázaro C; Casals T; Ravella A
    Hum Genet; 1991 Dec; 88(2):185-8. PubMed ID: 1757093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours.
    Bottillo I; Ahlquist T; Brekke H; Danielsen SA; van den Berg E; Mertens F; Lothe RA; Dallapiccola B
    J Pathol; 2009 Apr; 217(5):693-701. PubMed ID: 19142971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
    Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
    Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.